Last Update

This profile was last updated on 9/6/2016 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Ann Bass?

Ann D. Bass

Clinic Director

Neurology Center of San Antonio P.A

HQ Phone:  (210) 490-0016

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Neurology Center of San Antonio P.A

1314 East Sonterra Blvd. # 601

San Antonio, Texas, 78258

United States

Company Description

Neurology Center of San Antonio is a partnership of board-certified adult neurologists dedicated to providing compassionate and exemplary care and treatment to patients with neurological disorders. Our physicians and staff value the doctor-patient relationship...more

Find other employees at this company (5)

Background Information

Employment History

M.D., Emg and Ncv and Eeg and Ime

Nuerology Center of S.A.


Affiliations

Texas Medical Association

Active Member


Texas Neurological Society

Active Member


Bexar County Medical Society

Active Member


National Multiple Sclerosis Society

Medical Advisory Board


American Academy of Neurology

Active Member


MS Centers

Active Member


Education

M.S. Clinic Director


MD


medical degree

University of Texas Health Science Center


Web References(24 Total References)


| Family Life

Nearly 200 new cases of Multiple Sclerosis are diagnosed every week in the U.S. Family Life's Traci Lynn learns more about the disease with Dr. Ann Bass, the MS Clinical Director of the Neurology Center of San Antonio.


News Feature: Multiple Sclerosis - Family Life Podcasts

Nearly 200 new cases of Multiple Sclerosis are diagnosed every week in the U.S. Family Life's Traci Lynn learns more about the disease with Dr. Ann Bass, the MS Clinical Director of the Neurology Center of San Antonio.
Dr. Ann Bass mentioned several sites for people to learn more about MS and options: http://www.nationalmssociety.org/http://mymsaa.org/http://www.mscurefund.org/https://msfocus.org/


http://bioplushealth.com/bph/living-with-multiple-sclerosis/

NTV News spoke to Dr. Ann Bass, M.S. Clinic Director of the Neurology Center in San Antonio about Multiple Sclerosis.


Inside My Story | Life with Multiple Sclerosis & More | Page 2

Never one to turn down the opportunity to speak one on one with these specialists, I was happy to accept their offer and was connected with Dr. Ann Bass, from the Neurology Center of San Antonio.
Dr. Bass said the most obvious will be if a person fails two other types of drugs and is still relapsing. Dr. Bass said in the studies, 80% of the people were fine with treatment for just 2 yrs. Dr. Bass said the response is noted fairly fast, within the first few months for most people , with the full effect being felt in 6-12 months. It is no surprise that Dr. Bass said there is a neurologist online community that regularly talks and this is a hotly debated question, because no one really knows that answer. Dr. Bass says Lemtrada will be given by IV, the same as Campath, and the times will be similar. Since our interview I have thought of a few more questions, but I appreciated the openness Dr. Bass displayed discussing the pros and cons of Lemtrada. Thanks to a promotional outreach from a marketing firm to bloggers to talk about this program, I was able to speak by phone with Dr. Ann Bass, the director of The Neurology Center of San Antonio and the lead neurologist for this program. Lights, Camera, Take Action on MS will be comprised of three live events held on different dates in Chicago, Orlando and Houston. The Chicago and Orlando events will also be available to view on the web and taped for on demand viewing at their website. Each of these events will last about two hours, and have a panel comprised of Stowe, Bass, other as yet unspecified medical lifestyle support people, and their patient ambassadors. But Bass says the program will focus on more than just the Genzyme products and include mini-seminars that will offer information on ways to gain better health and be more active as people with MS. She is particularly excited to share the perspective Stowe will add to the caregivers' side of this disease; this is a special group of people that does so much but continues to be in the background with little support or resources


Inside My Story

The PR firm representing Genzyme Sanofi and the launch of their newest MS drug, contacted bloggers with the offer to speak with one of their neurologists about Lemtrada, the trade name for alemtuzamab.  Never one to turn down the opportunity to speak one on one with these specialists, I was happy to accept their offer and was connected with Dr. Ann Bass, from the Neurology Center of San Antonio.  Fortunately they allotted 30 minutes to talk by phone and we used every bit of that and could have used more. There is a lot to talk about - this new MS treatment option has the MS community buzzing with excitement about the potential.
Dr. Bass immediately pointed out something I had not caught â€"Lemtrada is approved for relapsing forms of MS and that is not limited to just Relapsing Remitting MS, and it could include Secondary progressive MS. She said there are no plans for a study for its use in primary progressive MS (PPMS), and cited an older study that showed the drug, alemtuzumab showed no benefit in PPMS.  I asked if there might be doctors who would try to use it off label for PPMS and she said that would be highly unlikely because of all the serious warnings that accompany this drug, and the extreme exposure to liability a doctor would face using it in an unapproved manner. Dr. Bass said in the studies, 80% of the people were fine with treatment for just 2 yrs. 20% needed an additional round for the third year and 10 % needed treatment for the fourth year.   The need for additional treatments is based on finding two indications that additional treatment is needed, and could include clinical evidence, EDSS changes, or new lesions and enhancing lesions on MRI exam. It is no surprise that Dr. Bass said there is a neurologist online community that regularly talks and this is a hotly debated question, because no one really knows that answer. Their big debate is while the  lymphocytes were repopulating would there be a benefit to be on something else? Dr. Bass says Lemtrada will be given by IV, the same as Campath, and the times will be similar. A treatment of Lemtrada will involve the infusion to take place over 4-6 hours and that an additional 2 hours of observation, making it at least an eight hour day. Because of the side effects of this drug which is a potent chemotherapy agent,  they recommend pretreating the person with other pharmaceutical to help counteract the side effects. Thanks to a promotional outreach  from a marketing firm to bloggers to talk about this program, I was able to speak by phone with Dr. Ann Bass, the director of The Neurology Center of San Antonio and the lead neurologist for this program. Lights, Camera, Take Action on MS will be comprised of  three live events held on different dates in Chicago, Orlando and Houston. The Chicago and Orlando events will also be available to view on the web and taped for on demand viewing at their website. Each of these events will last about two hours, and have a panel comprised of Stowe, Bass, other as yet unspecified medical lifestyle support people, and their patient ambassadors.  I won’t be anywhere near any of these locations to attend the live program and will have to settle for the rerun. The panel members will talk about their drug, of course, because that is required by the FDA laws governing contact with potential users of their drug. But Bass says the program will focus on more than just the Genzyme products and include mini-seminars that will offer information on ways to gain better health and be more active as people with MS. She is particularly excited to share the perspective Stowe will add to the caregivers’ side of this disease; this is a special group of people that does so much but continues to be in the background with little support or resources


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory